Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Allergan Sales, a wholly-owned subsidiary of Allergan, and QLT USA, a wholly-owned subsidiary of QLT, have announced the completion of Allergan's acquisition of QLT's Aczone gel 5% product, a topical treatment for acne vulgaris.
Subscribe to our email newsletter
As previously announced, Allergan paid approximately $150 million for all assets relating to Aczone gel 5%. Allergan expects to launch Aczone gel 5% in the fourth quarter of 2008 in the US and Canada.
David Pyott, chairman of the board and CEO of Allergan, said: “We are pleased with the opportunity to grow our franchise in medical dermatology where there is a continuous need for new treatment options and strong growth potential.”